Organon & Co (OGN) is now in the Undervalued zone, suggesting that its current forward PE ratio of 1.88 is considered Undervalued compared with the five-year average of 4.77. The fair price of Organon & Co (OGN) is between 31.79 to 40.80 according to relative valuation method. Compared to the current price of 7.15 USD , Organon & Co By Undervalued By 77.51%.

Relative Value

Fair Zone

31.79-40.80

Current Price：7.15

77.51%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Organon & Co (OGN) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Organon & Co (OGN) has a current Price-to-Book (P/B) ratio of 2.08. Compared to its 3-year average P/B ratio of 8.12, the current P/B ratio is approximately -74.42% higher. Relative to its 5-year average P/B ratio of 2.78, the current P/B ratio is about -25.33% higher. Organon & Co (OGN) has a Forward Free Cash Flow (FCF) yield of approximately 41.28%. Compared to its 3-year average FCF yield of 17.98%, the current FCF yield is approximately 129.64% lower. Relative to its 5-year average FCF yield of 18.34%, the current FCF yield is about 125.07% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for OGN competitors is 210.56, providing a benchmark for relative valuation. Organon & Co Corp (OGN.N) exhibits a P/S ratio of 0.31, which is -99.85% above the industry average. Given its robust revenue growth of -5.34%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of OGN increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of OGN in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is OGN currently overvalued or undervalued?

What is Organon & Co (OGN) fair value?

OGN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Organon & Co (OGN) is between 31.79 to 40.80 according to relative valuation method.

How does OGN's valuation metrics compare to the industry average?

The average P/S ratio for OGN's competitors is 210.56, providing a benchmark for relative valuation. Organon & Co Corp (OGN) exhibits a P/S ratio of 0.31, which is -99.85% above the industry average. Given its robust revenue growth of -5.34%, this premium appears unsustainable.

What is the current P/B ratio for Organon & Co (OGN) as of Mar 02 2026?

As of Mar 02 2026, Organon & Co (OGN) has a P/B ratio of 2.08. This indicates that the market values OGN at 2.08 times its book value.

What is the current FCF Yield for Organon & Co (OGN) as of Mar 02 2026?

As of Mar 02 2026, Organon & Co (OGN) has a FCF Yield of 41.28%. This means that for every dollar of Organon & Co's market capitalization, the company generates 41.28 cents in free cash flow.

What is the current Forward P/E ratio for Organon & Co (OGN) as of Mar 02 2026?

As of Mar 02 2026, Organon & Co (OGN) has a Forward P/E ratio of 1.88. This means the market is willing to pay $1.88 for every dollar of Organon & Co's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Organon & Co (OGN) as of Mar 02 2026?

As of Mar 02 2026, Organon & Co (OGN) has a Forward P/S ratio of 0.31. This means the market is valuing OGN at $0.31 for every dollar of expected revenue over the next 12 months.

OGN Valuation